Cayman Islands-based WuXi Healthcare Ventures Fund II, L.P. has filed paperwork with the US SEC for a $250 million life sciences venture fund. In March 2015, WuXi PharmaTech’s board of directors decided to commit up to $50 million as an anchor investment for WuXi Healthcare Ventures Fund II, with an additional $200 million to come from outside investors (see WuXi Form 20-F). In 2011, WuXi PharmaTech started its original WuXi Venture Fund with $50 million. By the end of 2014, it had invested $36.1 million in 18 life science companies and recognized gains of $16.6 million on exits. CORRECTION: WuXi PharmaTech is a separate and autonomous organization and did not file the Form D for the WuXi Healthcare Ventures Fund II, as previously reported (see story).
Help employers find you! Check out all the jobs and post your resume.
